Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Difficile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07613645
What this trial is testing

Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)

Who this might be right for
Clostridioides Difficile Infection
University of Michigan 20
Testing effectiveness (Phase 2)Study completedNCT01782755
What this trial is testing

Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial

Who this might be right for
Ventilator Associated Pneumonia (VAP)Other InfectionsAntibiotic-Associated Diarrhea+5 more
McMaster University 150
Early research (Phase 1)Enrolling By InvitationNCT01868373
What this trial is testing

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Who this might be right for
Active C. Difficile Colitis
Baylor College of Medicine 12
Not applicableStudy completedNCT01066221
What this trial is testing

Comparative Study of Three Different Testing Mechanisms for Clostridium Difficile

Who this might be right for
Clostridium Difficile
Hamilton Health Sciences Corporation 470
Testing effectiveness (Phase 2)Study completedNCT01559545
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Who this might be right for
Clostridium Difficile Associated Diarrhea
Dr. Reddy's Laboratories Limited 60
Testing effectiveness (Phase 2)Study completedNCT02148601
What this trial is testing

Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile
Catholic University of the Sacred Heart 39
Testing effectiveness (Phase 2)Study completedNCT03621657
What this trial is testing

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

Who this might be right for
Clostridium Difficile InfectionC.Difficile DiarrheaCDI
University of Wisconsin, Madison 1
Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Not applicableNot Yet RecruitingNCT07512908
What this trial is testing

Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Difficile in Infants

Who this might be right for
Bacteria Infection Mechanism
Fondation Hôpital Saint-Joseph 200
Not applicableWithdrawnNCT01472978
What this trial is testing

Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy

Who this might be right for
C. Difficile Infection
State University of New York at Buffalo
Early research (Phase 1)Ended earlyNCT03793686
What this trial is testing

Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Diarrhea
Prolacta Bioscience 26
Not applicableStudy completedNCT03117582
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Who this might be right for
Clostridium Difficile
University of North Carolina, Chapel Hill 34
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Early research (Phase 1)UnknownNCT02112279
What this trial is testing

Reduction of C-Difficile Infection Using Stool Transplant

Who this might be right for
C-difficile
Providence Holy Cross Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01680874
What this trial is testing

Probiotics for Clostridium Difficile Infection in Older Adults

Who this might be right for
Clostridium Difficile
University of Wisconsin, Madison 33
Large-scale testing (Phase 3)Ended earlyNCT03005379
What this trial is testing

Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

Who this might be right for
Clostridium Difficile Infection
VA Office of Research and Development 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Testing effectiveness (Phase 2)Study completedNCT01230957
What this trial is testing

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Sanofi Pasteur, a Sanofi Company 650
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Next Page